Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Neuronetics, Inc. develops non-invasive neurohealth treatments, primarily using transcranial magnetic stimulation (TMS) for major depressive disorder (MDD) and other mental health conditions. Its flagship product, the NeuroStar Advanced Therapy System, delivers precise magnetic pulses to stimulate mood-related brain areas. The company operates in the U.S. and internationally, serving psychiatrists and mental health providers with clinical data-backed solutions, practice support, and expanding indications in the neurotherapy market.
This description was generated via AI from an annual report. Updated about 1 year ago.